Dogdus, M. Et Al. 2021. Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention. Angiology , vol.72, no.3 , 221-227.

Dogdus, M., Yenercag, M., Ozyasar, M., Yilmaz, A., Can, L. H., & Kultursay, H., (2021). Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention. Angiology , vol.72, no.3, 221-227.

Dogdus, Mustafa Et Al. "Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention," Angiology , vol.72, no.3, 221-227, 2021

Dogdus, Mustafa Et Al. "Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention." Angiology , vol.72, no.3, pp.221-227, 2021

Dogdus, M. Et Al. (2021) . "Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention." Angiology , vol.72, no.3, pp.221-227.

@article{article, author={Mustafa Dogdus Et Al. }, title={Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention}, journal={Angiology}, year=2021, pages={221-227} }